Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.
Schwab
G
G
Hecht
T
T
D016026:Bone Marrow Transplantation; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D000069585:Filgrastim; D005544:Forecasting; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim